Orbimed Advisors - PRELUDE THERAPEUTICS INC ownership

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 61 filers reported holding PRELUDE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of PRELUDE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$33,709,601
-31.3%
10,909,2560.0%0.72%
-19.6%
Q2 2023$49,091,652
-14.2%
10,909,256
+8.7%
0.89%
-20.7%
Q1 2023$57,226,239
-5.6%
10,039,6910.0%1.12%
-3.2%
Q4 2022$60,639,734
-8.6%
10,039,6910.0%1.16%
-5.8%
Q3 2022$66,362,000
+26.6%
10,039,6910.0%1.23%
+29.7%
Q2 2022$52,407,000
-24.3%
10,039,6910.0%0.95%
-15.4%
Q1 2022$69,274,000
-44.6%
10,039,6910.0%1.12%
-30.1%
Q4 2021$124,994,000
-60.2%
10,039,6910.0%1.61%
-53.4%
Q3 2021$313,740,000
+9.2%
10,039,6910.0%3.45%
+18.6%
Q2 2021$287,436,000
-33.9%
10,039,6910.0%2.91%
-28.5%
Q1 2021$435,020,000
-61.0%
10,039,691
-35.6%
4.07%
-58.3%
Q4 2020$1,115,813,000
+137.5%
15,594,8770.0%9.76%
+65.3%
Q3 2020$469,874,00015,594,8775.91%
Other shareholders
PRELUDE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Orbimed Advisors 10,909,256$33,709,6010.72%
Boxer Capital, LLC 2,495,018$7,709,6060.41%
Sio Capital Management, LLC 350,000$1,081,5000.34%
Baker Brothers Advisors 10,123,824$31,282,6160.18%
EcoR1 Capital, LLC 1,157,452$3,576,5270.12%
GSA CAPITAL PARTNERS LLP 70,583$2180.02%
Pale Fire Capital SE 30,781$95,1130.01%
Woodline Partners LP 200,000$618,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 143,957$444,8270.00%
EXCHANGE TRADED CONCEPTS, LLC 32,907$101,6830.00%
View complete list of PRELUDE THERAPEUTICS INC shareholders